We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
NEJM reports on gene therapy for narcolepsy in mice, but Takeda is already preparing to launch oveporexone. Analysis of why a pill beats an injection into the brain. Read the details.
